Journal of Hematopathology (2017) 10:117–127 https://doi.org/10.1007/s12308-017-0310-2 REVIEW OF THE LITERATURE New developments in the pathology of malignant lymphoma. A review of the literature published from September–August 2017 J. H. van Krieken Published online: 29 November 2017 The Author(s) 2017. This article is an open access publication Introduction swath of EBER+ neoplastic cells accompanied by a rela- tive absence of reactive T cells. In all 3 cases, the cells in As I wrote in the editorial in this issue , it is rare to see EBER+ areas expressed latent membrane protein-1 and single-authored original articles in the medical literature, were strongly positive for CD30. Miller concluded that but in this review, there is an exception. I.J. Miller re- these three cases suggest that in a subset of EBV+ trieved 46 cases of Epstein Bar virus (EBV) positive lym- DLBCLs, EBV infection may not be the “first hit.” Anice phomas from the archives of his laboratory and looked piece of work, which indeed can be done by a single carefully at the distribution of EBV early RNA (EBER)- person. Nevertheless, it is my experience that discussion positive cells . I imagine that he or she was reviewing a on data improve
Journal of Hematopathology – Springer Journals
Published: Nov 29, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud